SALT LAKE CITY, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq:

Health Catalyst (NASDAQ: HCAT - Get Free Report) and Aclarion (NASDAQ: ACONW - Get Free Report) are

Wall Street analysts changed ratings for top stocks. See full list at Benzinga's analyst ratings

Canaccord Genuity analyst Richard Close downgrades Health Catalyst (NASDAQ:HCAT) from Buy to Hold

Wells Fargo analyst Stan Berenshteyn maintains Health Catalyst (NASDAQ:HCAT) with a Equal-Weight

Health Catalyst, Inc. (NASDAQ: HCAT - Get Free Report) has earned an average rating of "Hold" from t

Health Catalyst (NASDAQ: HCAT - Get Free Report) and Lynx Global Digital Finance (OTCMKTS:CNONF - Ge

Citigroup analyst Daniel Grosslight maintains Health Catalyst (NASDAQ:HCAT) with a Neutral and lo

Gainers AVITA Medical (NASDAQ:RCEL) stock rose 58.4% to $7.53 during Friday's regular session.

Gainers Doximity (NYSE:DOCS) stock rose 85.1% to $38.25 during Friday's pre-market session. The

Atlassian Corp (NASDAQ: TEAM) reported strong Q4 results, beating revenue and earnings estimates. St

Health Catalyst stock fell after hours after reporting Q2 results and issuing weaker third-quarter r

Health Catalyst NASDAQ: HCAT reported second-quarter 2026 revenue above the high end of its guidance

Health Catalyst, Inc. (HCAT) Q2 2026 Earnings Call Transcript

Although the revenue and EPS for Health Catalyst (HCAT) give a sense of how its business performed i

Health Catalyst (HCAT) came out with quarterly earnings of $0.04 per share, beating the Zacks Consen

Gainers Doximity (NYSE:DOCS) stock increased by 65.6% to $34.22 during Thursday's after-market

Health Catalyst (NASDAQ:HCAT) sees FY2026 sales of $246.000 million-$249.000 million vs $260.780 mil

Health Catalyst (NASDAQ:HCAT) reported quarterly earnings of $0.04 per share which beat the analyst

SALT LAKE CITY, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq:

Company retires all credit facility debt; transaction reflects concentrating its technology on impro

SALT LAKE CITY, July 28, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst”, Nasdaq:

Canaccord Genuity analyst Richard Close maintains Health Catalyst (NASDAQ:HCAT) with a Buy and ra

Health Catalyst NASDAQ: HCAT stockholders approved three of four proposals presented at the company'

Wells Fargo analyst Stan Berenshteyn maintains Health Catalyst (NASDAQ:HCAT) with a Equal-Weight

SALT LAKE CITY, June 16, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq:

PARSIPPANY, N.J., June 4, 2026 /PRNewswire/ -- Med-Metrix, LLC ("Med-Metrix"), backed by Harvest Par

Health Catalyst, Inc. (("Health Catalyst" or the "Company, NASDAQ:HCAT) today announced

Health Catalyst today announced it has signed a definitive agreement to divest Vitalware, its mid-re

Stephens & Co. analyst Jeff Garro maintains Health Catalyst (NASDAQ:HCAT) with a Equal-Weight

Health Catalyst, Inc. (HCAT) Q1 2026 Earnings Call Transcript

Health Catalyst NASDAQ: HCAT reported first-quarter 2026 results that topped its own expectations, w

Health Catalyst (HCAT) came out with quarterly earnings of $0.02 per share, beating the Zacks Consen

While the top- and bottom-line numbers for Health Catalyst (HCAT) give a sense of how the business p

Health Catalyst (NASDAQ:HCAT) reported quarterly earnings of $0.02 per share which met the analyst c

SALT LAKE CITY, May 11, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: H

Evaluate the expected performance of Health Catalyst (HCAT) for the quarter ended March 2026, lookin

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;

Wells Fargo analyst Stan Berenshteyn downgrades Health Catalyst (NASDAQ:HCAT) from Overweight to

Citigroup analyst Daniel Grosslight maintains Health Catalyst (NASDAQ:HCAT) with a Neutral and lo

Canaccord Genuity analyst Richard Close maintains Health Catalyst (NASDAQ:HCAT) with a Buy and lo

Stephens & Co. analyst Jeff Garro maintains Health Catalyst (NASDAQ:HCAT) with a Equal-Weight

Stifel analyst David Grossman maintains Health Catalyst (NASDAQ:HCAT) with a Hold and lowers the

Cantor Fitzgerald analyst Sarah James maintains Health Catalyst (NASDAQ:HCAT) with a Neutral and

Health Catalyst (NASDAQ:HCAT) reported quarterly earnings of $0.08 per share which missed the analys